BHIVA Satellite Symposium

Slides:



Advertisements
Similar presentations
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Advertisements

Cristin Muecke, RMOH Nick Scott, ED AIDS NB.  Why HIV testing remains important  Treatment as prevention  Discuss advantages/disadvantages of various.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Maurice Cook ( EM Designs Group, Inc.) The End of AIDS Transmission? Robert M Grant, June 2012.
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
Professor Graham J Hart PhD Sexual Health Promotion & HIV Prevention for HIV Positive MSM: Issues & Challenges Centre for Sexual Health & HIV Research.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
Embedding Open-label PrEP trial in expansion of UK HIV Prevention Programme.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
TRACK C RAPPORTEURS REPORT. Prepared by Anne BuvéBelgium Anne BuvéBelgium Sabina Bindra-BarnesIndia Sabina Bindra-BarnesIndia Saidi KapigaTanzania Saidi.
Michael Hughes, MD Assistant Clinical Professor UCR Eisenhower Medical Associates.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
Pharmacist-Managed HIV Pre-Exposure Prophylaxis (PrEP) Clinic: Preliminary Outcomes From an Urban Community Health Clinic Mark T. Sawkin, PharmD, AAHIVP.
IAS July 1 The Caprisa 004 result in context Sheena McCormack Clinical Scientist MRC Clinical Trials Unit.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER HIV Prevention in Clinical Care Settings Jeanne Marrazzo, MD, MPH Professor, Division of Allergy and Infectious.
Prevention Science Gaps and the HIV/AIDS Pandemic Quarraisha Abdool Karim, PhD Head: CAPRISA Women and AIDS Pogramme Associate Professor in Epidemiology,
Establishment of a monitoring service for men who have sex with men (MSM) taking generic co-formulated tenofovir disoproxil fumarate (TDF)/emtricitabine.
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
Expanded PrEP implementation in NSW (EPIC-NSW) 1 AIDS 2016 | 22 July 2016.
Pre-exposure Prophylaxis (PrEP) for HIV Prevention: What’s the Future? Joanne Stekler, MD MPH Assistant Professor of Medicine University of Washington.
Providing PrEP – The Basics
PRE-EXPOSURE PROPHYLAXIS in Pregnancy in South Africa
Information about HIV Prevention Options
IAS Satellite Session 25th July 2017 Daniel Were, PhD
PrEP for HIV Prevention
HIV Post Exposure Prophylaxis
Module 4 (e) Pregnancy and Breast Feeding
56 Dean Street, Chelsea and Westminster Hospital, London
“Its Different Now”: The Changing Landscape of HIV testing
TransIT The Transgender Implementation Tool for the WHO key population guidelines.
STRATEGIES FOR STI PREVENTION AND CONTROL
A protocol in development IMPAACT Prevention Scientific Committee
Zimbabwe’s shift towards treat all: national country context
1st International Online BioMedical Conference (IOBMC 2015)
COMBINATION PREVENTION
Antiretroviral Therapy (ART) for HIV Prevention:
PrEP as an HIV Prevention Tool in Queer Communities of Color: Barriers and Opportunities BACKGROUND Joanne Stekler, MD MPH.
Pre-exposure Prophylaxis (PrEP)
David Magnuson, Trevor Hawkins, Robertino Mera
One pill a day, can keep HIV away
John de Wit1,2, Dean Murphy2,3, Luxi Lal4,5,6, Jennifer Audsley5,7, Christopher K. Fairley8,9, Mark Stoove4,10, Norm Roth11, Richard Moore12, Ban K.
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Overview of importance and emerging innovations for testing and linkage CHERYL JOHNSON WORLD HEALTH ORGANIZATION HIV AND HEPATITIS DEPARTMENT 23 JULY.
Brief overview of HIV among MSM in the EU/EEA
The Politics of PrEP The French Experience
National Department of Health: South Africa
Global Optimization of the Response to HIV
STIs among people who use drugs
100 Partners PrEP[5] Efficacy 75% Adherence 81% 80
HIV.
Impact of Tenofovir Chemoprophylaxis on HIV Prevention Programs Questions and Implications from Local Experience Charles L. Henry, Director County of Los.
Lesson 3: Treatment as Prevention
Illustrative Cluster Detection and Response Strategy
U=U Guidance for Implementation in Clinical Settings
PrEP in Brazil: 18 months of implementation as a public health policy
Overview of HIV Prevention Cascade Discussions. Geoff Garnett
Reshmie Ramautarsing, M.D., Ph.D.
Bob Holtkamp, Director of Prevention & Outreach
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

BHIVA Satellite Symposium Tougher Times: Adapting to Increasing Demand with Declining Resources Monday 24 July 2017

Prevention: Supporting Generic PrEP Access and Offering Monitoring – Legalities and Practicalities Efficiencies Viewed Through 90:90:90 Dr Nneka Nwokolo 56 Dean Street, Chelsea and Westminster Hospital, London

Speaker Name Disclosure Statement Dr Nneka Nwokolo Dr Nwokolo has received speaker fees, honororaria and support for attendance at conferences from Gilead Sciences, Viiv, GSK, Janssen Date 16th July 2017

By 2020, 90% of all people living with HIV will know their HIV status By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression

To end the AIDS epidemic Diagnose undiagnosed Treat diagnosed Prevent infection in those at risk

Combination prevention is key UNAIDS (2010) provides the following definition of combination HIV prevention: “The strategic, simultaneous use of different classes of prevention activities (biomedical, behavioral, social/structural) that operate on multiple levels (individual, relationship, community, societal), to respond to the specific needs of particular audiences and modes of HIV transmission, and to make efficient use of resources through prioritizing, partnership, and engagement of affected communities” Discussion draft for UNAIDS HIV Prevention Reference Group meeting 2009

Combination prevention Biomedical – e.g. male circumcision, PrEP, TasP Behavioural – e.g. testing, condom use, delayed coitarche, serosorting, safe injecting practices Structural – e.g. programmes or frameworks to enable or encourage safe behaviour, create safe environments and facilitate access to testing, treatment or other interventions

Exactly how important is PrEP? Condoms – cornerstone of HIV prevention for decades Consistent condom use impossible in 100% of people 100% of the time No single intervention has provided as dramatic a reduction in HIV transmission as PrEP

Summary of PrEP trials

Where has PrEP been approved? Australia Belgium Canada France Kenya Norway Peru Scotland South Africa USA Zimbabwe Brazil, Thailand in process of approval

But most countries DON’T have PrEP programmes! People forced to purchase Truvada at significant cost (£400/month) “Clinic hopping” for PEP Using HIV+ friends’ Truvada Smuggling PrEP into countries Purchasing generic TDF/FTC online

Producers of generic PrEP Pharmaceutical companies whom Gilead has given licence to produce generic TDF/TFC for use in HIV treatment programmes in developing world e.g. Cipla – India: Tenvir EM Mylan – US/Netherlands: Ricovir EM Emcure – India: Tavin EM

Fears about counterfeit TDF/FTC have not been borne out Wang X et al. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London – analysis of pharmacokinetics, safety and outcomes. HIV Med 2017doi:10.1111/hiv.12528

But is it legal to purchase PrEP online? In many countries, it is illegal to purchase medicines online In the UK medicines can be purchased online if: - They are for personal use (3 months or less) - They are not illegal or restricted drugs e.g. narcotics MHRA – be careful

What are our responsibilities? UK General Medical Council: - Clinicians have a duty of care to individuals at risk of acquiring HIV - Doctors should give patients the information they want and need about options for treating and managing their condition, the potential benefits, burdens and risks for each option, and any treatments that they think have greater potential benefit for the patient than they or their organization can offer

Practicalities September 2015 56 Dean Street set up service to enable people to purchase Truvada at NHS list price with monitoring (HIV testing, STI screening, renal function testing) on the NHS) Rapidly found that people were purchasing PrEP online and coming to the clinic for monitoring February 2016, set up PrEP monitoring in general sexual health service Other London clinics also started to do the same

PrEP assessment and monitoring Patients see doctor or nurse for discussion Identification and management of high risk behaviour e.g. chemsex Offering other risk reduction interventions – Dean Street PRIME (Just us; Condoms +; Take a Break; PrEP; Total Bareback)

Monitoring Hepatitis C testing according to risk

Dramatic and unexpected result!

56 Dean Street PrEP monitoring results 641 individuals on generic PrEP 336 person-years of follow-up 75% daily PrEP; 14% event driven No counterfeit TDF/FTC No significant renal adverse events No new cases of HIV or hepatitis B 2 new cases of hepatitis C 10% increase in STIs

Effects of combined interventions Early diagnosis and treatment of HIV Dean Street Express effect: rapid diagnosis and treatment of STIs PrEP Dean Street PRIME effect: monthly HIV and STI testing 54% reduction in STIs overall; 24% reduction in GC No new HIV infections

Now what?

While PrEP not nationally available Identify individuals at risk Provide information Follow guidelines Incorporate PrEP monitoring into routine STI screening

Risk factors for HIV acquisition MSM - Condomless anal sex with partner of unknown HIV status or HIV + not on treatment - Bacterial rectal STI - Syphilis HIV - partner of HIV + person with detectable VL Anyone clinically assessed to be at similar risk to individuals above

Information www.iwantprepnow.co.uk – how to access online PrEP www.prepster.info www.eatg.org - PrEP access in Europe http://i-base.info/guides/prep WHO PrEP Implementation tool

Guidelines PrEPwatch – regularly updated list of international PrEP guidelines http://www.prepwatch.org/policies-and-programs/guidelines-tools/healthcare-providers/

Messages Estimated 6000 on PrEP in UK Learning as we go along! Partnering with community groups is crucial

Challenges Ensuring that individuals accessing PrEP online access monitoring Identifying non-MSM individuals at risk and promoting PrEP to them; engaging non-users of internet/social media Creating capacity in sexual health clinics – telephone consultations; home/postal testing – fingerprick samples for HIV/syphilis/hepatitis serology/renal function; STI screening Controlling STIs

Are you ready?

Thank you